Early phase combined therapeutic management of acute ischaemic stroke View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-05

AUTHORS

P. Bassi, P. Lattuada, S. Tonietti

ABSTRACT

An adequate treatment of ischaemic stroke in the early phase (28–48 h) is the most important factor for a better outcome. Thrombolysis with rTPA (within 3 h) and oral ASA 300 mg/days are the first therapeutic misures. Continuous monitoring of cardiological and haemodinamic parameters allows early detection of cardiac disturbances. Treatment of hypertension, low haematic oxigenation, hyperglicaemia, seizures and hypertermia is basic to improve outcome. Pharmacological therapy is only one of the components of effective multidisciplinary integrated managment of ischaemic stroke; we remind also the precocity of rehabilitation procedures and an accurate psychological assessment. More... »

PAGES

s29-s30

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10072-005-0400-1

DOI

http://dx.doi.org/10.1007/s10072-005-0400-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1011754363

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/15883687


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain Ischemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Emergency Treatment", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fibrinolytic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rehabilitation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thrombolytic Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Plasminogen Activator", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.414126.4", 
          "name": [
            "Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bassi", 
        "givenName": "P.", 
        "id": "sg:person.01244141046.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244141046.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.414126.4", 
          "name": [
            "Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lattuada", 
        "givenName": "P.", 
        "id": "sg:person.01023024636.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023024636.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy", 
          "id": "http://www.grid.ac/institutes/grid.414126.4", 
          "name": [
            "Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tonietti", 
        "givenName": "S.", 
        "type": "Person"
      }
    ], 
    "datePublished": "2005-05", 
    "datePublishedReg": "2005-05-01", 
    "description": "An adequate treatment of ischaemic stroke in the early phase (28\u201348 h) is the most important factor for a better outcome. Thrombolysis with rTPA (within 3 h) and oral ASA 300 mg/days are the first therapeutic misures. Continuous monitoring of cardiological and haemodinamic parameters allows early detection of cardiac disturbances. Treatment of hypertension, low haematic oxigenation, hyperglicaemia, seizures and hypertermia is basic to improve outcome. Pharmacological therapy is only one of the components of effective multidisciplinary integrated managment of ischaemic stroke; we remind also the precocity of rehabilitation procedures and an accurate psychological assessment.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s10072-005-0400-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1294956", 
        "issn": [
          "1590-1874", 
          "1126-5442"
        ], 
        "name": "Neurological Sciences", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "26"
      }
    ], 
    "keywords": [
      "ischemic stroke", 
      "accurate psychological assessment", 
      "acute ischemic stroke", 
      "treatment of hypertension", 
      "early phase", 
      "oral ASA", 
      "pharmacological therapy", 
      "cardiac disturbances", 
      "therapeutic management", 
      "effective multidisciplinary", 
      "better outcomes", 
      "adequate treatment", 
      "early detection", 
      "stroke", 
      "rehabilitation procedures", 
      "psychological assessment", 
      "outcomes", 
      "treatment", 
      "thrombolysis", 
      "hypertension", 
      "seizures", 
      "therapy", 
      "rtPA", 
      "continuous monitoring", 
      "hypertermia", 
      "days", 
      "ASA", 
      "important factor", 
      "multidisciplinary", 
      "hyperglicaemia", 
      "managment", 
      "assessment", 
      "management", 
      "factors", 
      "disturbances", 
      "procedure", 
      "precocity", 
      "monitoring", 
      "detection", 
      "phase", 
      "components", 
      "parameters", 
      "first therapeutic misures", 
      "therapeutic misures", 
      "misures", 
      "haemodinamic parameters", 
      "low haematic oxigenation", 
      "haematic oxigenation", 
      "oxigenation"
    ], 
    "name": "Early phase combined therapeutic management of acute ischaemic stroke", 
    "pagination": "s29-s30", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1011754363"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10072-005-0400-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "15883687"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10072-005-0400-1", 
      "https://app.dimensions.ai/details/publication/pub.1011754363"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-11-01T18:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/article/article_410.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s10072-005-0400-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10072-005-0400-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10072-005-0400-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10072-005-0400-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10072-005-0400-1'


 

This table displays all metadata directly associated to this object as RDF triples.

164 TRIPLES      21 PREDICATES      86 URIs      78 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10072-005-0400-1 schema:about N1dbf2c13fe7f4cff88780ca6986fd725
2 N4849691889894b5ba0c55f5e73fdeed5
3 N5b78fdce27f54498a0e23fe7d97c78ff
4 N5d581389865e49dd9cef01ffd4ce395d
5 N63cf5c57cbf344b1a6734dfba040b7f1
6 N6949d6ade6bc4f0ba07d8dbbb232ec2e
7 N7b1c2db6fe40449baaabac36cd11d065
8 N89cdda995e314453993aabe0c0fe77c8
9 Na225236556b440e2bbe87a2ee8e27bdd
10 Nf3b0e32cce914731b761c1eeab3e7118
11 anzsrc-for:11
12 anzsrc-for:1109
13 schema:author N21ad0985a57a4f05927920e65e352a85
14 schema:datePublished 2005-05
15 schema:datePublishedReg 2005-05-01
16 schema:description An adequate treatment of ischaemic stroke in the early phase (28–48 h) is the most important factor for a better outcome. Thrombolysis with rTPA (within 3 h) and oral ASA 300 mg/days are the first therapeutic misures. Continuous monitoring of cardiological and haemodinamic parameters allows early detection of cardiac disturbances. Treatment of hypertension, low haematic oxigenation, hyperglicaemia, seizures and hypertermia is basic to improve outcome. Pharmacological therapy is only one of the components of effective multidisciplinary integrated managment of ischaemic stroke; we remind also the precocity of rehabilitation procedures and an accurate psychological assessment.
17 schema:genre article
18 schema:inLanguage en
19 schema:isAccessibleForFree false
20 schema:isPartOf N45b142cd94f348d4b477bcd4581b3c0b
21 Nb33cf9dd34674cd89ee2dbce20a8a312
22 sg:journal.1294956
23 schema:keywords ASA
24 accurate psychological assessment
25 acute ischemic stroke
26 adequate treatment
27 assessment
28 better outcomes
29 cardiac disturbances
30 components
31 continuous monitoring
32 days
33 detection
34 disturbances
35 early detection
36 early phase
37 effective multidisciplinary
38 factors
39 first therapeutic misures
40 haematic oxigenation
41 haemodinamic parameters
42 hyperglicaemia
43 hypertension
44 hypertermia
45 important factor
46 ischemic stroke
47 low haematic oxigenation
48 management
49 managment
50 misures
51 monitoring
52 multidisciplinary
53 oral ASA
54 outcomes
55 oxigenation
56 parameters
57 pharmacological therapy
58 phase
59 precocity
60 procedure
61 psychological assessment
62 rehabilitation procedures
63 rtPA
64 seizures
65 stroke
66 therapeutic management
67 therapeutic misures
68 therapy
69 thrombolysis
70 treatment
71 treatment of hypertension
72 schema:name Early phase combined therapeutic management of acute ischaemic stroke
73 schema:pagination s29-s30
74 schema:productId N036b066bace745e2a3713dd1977bcbf0
75 N5fc92c5037fe49bf8c69b992a1977544
76 N8897b4fb72c844f8a3100ed8be70706f
77 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011754363
78 https://doi.org/10.1007/s10072-005-0400-1
79 schema:sdDatePublished 2021-11-01T18:08
80 schema:sdLicense https://scigraph.springernature.com/explorer/license/
81 schema:sdPublisher N9bb0dc5b93b744eab40d9014407961fa
82 schema:url https://doi.org/10.1007/s10072-005-0400-1
83 sgo:license sg:explorer/license/
84 sgo:sdDataset articles
85 rdf:type schema:ScholarlyArticle
86 N036b066bace745e2a3713dd1977bcbf0 schema:name doi
87 schema:value 10.1007/s10072-005-0400-1
88 rdf:type schema:PropertyValue
89 N1dbf2c13fe7f4cff88780ca6986fd725 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Rehabilitation
91 rdf:type schema:DefinedTerm
92 N21ad0985a57a4f05927920e65e352a85 rdf:first sg:person.01244141046.09
93 rdf:rest Ncca3298d111b4445bca59d584be23db4
94 N3b532b50ceda4f879b9c7863b12dc146 schema:affiliation grid-institutes:grid.414126.4
95 schema:familyName Tonietti
96 schema:givenName S.
97 rdf:type schema:Person
98 N45b142cd94f348d4b477bcd4581b3c0b schema:issueNumber Suppl 1
99 rdf:type schema:PublicationIssue
100 N4849691889894b5ba0c55f5e73fdeed5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Fibrinolytic Agents
102 rdf:type schema:DefinedTerm
103 N5b78fdce27f54498a0e23fe7d97c78ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Tissue Plasminogen Activator
105 rdf:type schema:DefinedTerm
106 N5d581389865e49dd9cef01ffd4ce395d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Humans
108 rdf:type schema:DefinedTerm
109 N5fc92c5037fe49bf8c69b992a1977544 schema:name dimensions_id
110 schema:value pub.1011754363
111 rdf:type schema:PropertyValue
112 N63cf5c57cbf344b1a6734dfba040b7f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Brain Ischemia
114 rdf:type schema:DefinedTerm
115 N6949d6ade6bc4f0ba07d8dbbb232ec2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Acute Disease
117 rdf:type schema:DefinedTerm
118 N7b1c2db6fe40449baaabac36cd11d065 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Thrombolytic Therapy
120 rdf:type schema:DefinedTerm
121 N8897b4fb72c844f8a3100ed8be70706f schema:name pubmed_id
122 schema:value 15883687
123 rdf:type schema:PropertyValue
124 N89cdda995e314453993aabe0c0fe77c8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Time Factors
126 rdf:type schema:DefinedTerm
127 N9bb0dc5b93b744eab40d9014407961fa schema:name Springer Nature - SN SciGraph project
128 rdf:type schema:Organization
129 Na225236556b440e2bbe87a2ee8e27bdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Emergency Treatment
131 rdf:type schema:DefinedTerm
132 Nb33cf9dd34674cd89ee2dbce20a8a312 schema:volumeNumber 26
133 rdf:type schema:PublicationVolume
134 Nc2277bf8791242eea696020a9e8ce225 rdf:first N3b532b50ceda4f879b9c7863b12dc146
135 rdf:rest rdf:nil
136 Ncca3298d111b4445bca59d584be23db4 rdf:first sg:person.01023024636.24
137 rdf:rest Nc2277bf8791242eea696020a9e8ce225
138 Nf3b0e32cce914731b761c1eeab3e7118 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Treatment Outcome
140 rdf:type schema:DefinedTerm
141 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
142 schema:name Medical and Health Sciences
143 rdf:type schema:DefinedTerm
144 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
145 schema:name Neurosciences
146 rdf:type schema:DefinedTerm
147 sg:journal.1294956 schema:issn 1126-5442
148 1590-1874
149 schema:name Neurological Sciences
150 schema:publisher Springer Nature
151 rdf:type schema:Periodical
152 sg:person.01023024636.24 schema:affiliation grid-institutes:grid.414126.4
153 schema:familyName Lattuada
154 schema:givenName P.
155 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023024636.24
156 rdf:type schema:Person
157 sg:person.01244141046.09 schema:affiliation grid-institutes:grid.414126.4
158 schema:familyName Bassi
159 schema:givenName P.
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01244141046.09
161 rdf:type schema:Person
162 grid-institutes:grid.414126.4 schema:alternateName Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy
163 schema:name Neurological Department, San Carlo Borromeo Hospital, Via Pio II 3, I-20153, Milan, Italy
164 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...